Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells
2014
The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome
2016 Standout
PDF Cells Are a GABA-Responsive Wake-Promoting Component of the Drosophila Sleep Circuit
2008 StandoutNobel
Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System
2009
Hypocretin/orexin and energy expenditure
2010
The Hypothalamic Orexinergic System: Pain and Primary Headaches
2007
Optogenetic deconstruction of sleep-wake circuitry in the brain
2010
A global view of pulmonary hypertension
2016 Standout
Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonists
2011
Future Coastal Population Growth and Exposure to Sea-Level Rise and Coastal Flooding - A Global Assessment
2015 Standout
Systemic sclerosis
2017 Standout
Changes in causes of death in systemic sclerosis, 1972–2002
2007 Standout
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
2015
Macitentan in pulmonary arterial hypertension: The SERAPHIN trial
2014
Sleep Deprivation Effects on Circadian Clock Gene Expression in the Cerebral Cortex Parallel Electroencephalographic Differences among Mouse Strains
2008 StandoutNobel
How to fix a broken clock
2013
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
2007
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
The use of spirocyclic scaffolds in drug discovery
2014 Standout
Orexin receptors as therapeutic drug targets
2012
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
The Future of Peptide‐based Drugs
2012 Standout
The hyperarousal model of insomnia: A review of the concept and its evidence
2009
The Implications of Multiple Circadian Clock Origins
2009 StandoutNobel
Sleep disorders, obesity, and aging: The role of orexin
2014
Synthetic approaches to the 2013 new drugs
2015
Enantioselective synthesis of almorexant via iridium-catalysed intramolecular allylic amidation
2013 StandoutNobel
Orexin Receptor Antagonists: A New Concept In CNS Disorders?
2010
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Mammalian circadian signaling networks and therapeutic targets
2007
What’s new in the treatment of portopulmonary hypertension?
2015
Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies
2011 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic Cooperation
2011 Standout
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
2013
Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
2013
Genome-Wide Association Studies of Sleep Disorders
2011
Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet
2017 Standout
Macitentan: entry-into-humans study with a new endothelin receptor antagonist
2011
Ambrisentan, a Non‐peptide Endothelin Receptor Antagonist
2006
Over One Hundred Peptide-Activated G Protein-Coupled Receptors Recognize Ligands with Turn Structure
2005
Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis
2016 Standout
Recent advances in the synthesis of pyrroles by multicomponent reactions
2014 Standout
Pulmonary Arterial Hypertension
2006
Phosphine Organocatalysis
2018 Standout
Control of Sleep and Wakefulness
2012
Catalytic Enantioselective Synthesis of Atropisomeric Biaryls: A Cation‐Directed Nucleophilic Aromatic Substitution Reaction
2014
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
2014
Multicomponent reactions: advanced tools for sustainable organic synthesis
2014 Standout
Biomedical Application of Orexin/Hypocretin Receptor Ligands in Neuroscience
2009
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
2013
About Sleep's Role in Memory
2013 Standout
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis
2016
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Microglial M1/M2 polarization and metabolic states
2015 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
One-Pot Phosphine-Catalyzed Syntheses of Quinolines
2012
Recent advances and new concepts for the synthesis of axially stereoenriched biaryls
2015 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Metal-Free Multicomponent Syntheses of Pyridines
2014 Standout
Works of Stephan Buchmann being referenced
Promotion of sleep by targeting the orexin system in rats, dogs and humans
2007
Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
2008
The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist
2012
Novel Benzo[1,4]diazepin-2-one Derivatives as Endothelin Receptor Antagonists
2004